ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX

Rosen Law Firm has filed a class action lawsuit on behalf of Ardelyx, Inc. investors who purchased stock between January 13, 2025 and August 6, 2026. The lawsuit alleges that Ardelyx provided materially false and misleading statements regarding commercial performance and growth prospects for its drugs XPHOZAH and IBSRELA, while concealing information about payer access barriers, prior authorization requirements, and step edit requirements that hindered patient access and prescription fulfillment. Investors who wish to serve as lead plaintiff must file by November 16, 2026.